David Goldberg is Associate Professor of Medicine in the Division of Digestive Health and Liver Diseases at the University of Miami Miller School of Medicine. Dr. Goldberg specializes in the care of patients with chronic liver disease and cirrhosis, including patients waitlisted for a liver transplant. His research focuses on several areas, including 1) disparities in access-to-care for patients with end-stage liver disease and hepatocellular carcinoma; 2) optimizing allocation of livers for transplantation; 3) using novel biostatistical methods to better characterize donor allograft quality, predict transplant outcomes, and expand access to kidney and liver transplantation; 4) increasing the number of life-saving organ transplants by transplanting organs from deceased donors with Hepatitis C into Hepatitis C-negative recipients. Dr. Goldberg has received funding from the National Institutes of Health, private foundations, and the pharmaceutical industry (via investigator-initiated grants). Dr. Goldberg has published more than 100 peer-reviewed publications including first-author papers in the New England Journal of Medicine and JAMA. Dr. Goldberg was the co-PI of the first published clinical trial of transplanting kidneys from Hepatitis C-infected donors into Hepatitis C-negative recipients.